Here's a quick look at some recent analyst ratings and price target adjustments that investors should be aware of. Several companies have been under the microscope, with analysts weighing in on their potential.
Close Brothers Group Receives "Buy" Reiteration
Close Brothers Group (LON:CBG) received a vote of confidence from Shore Capital, who reiterated their "buy" rating on the stock, according to Digital Look. However, Deutsche Bank Aktiengesellschaft took a slightly more cautious stance, reducing their price target from GBX 610 ($7.80) to GBX 600 ($7.68) and issuing a "hold" rating.
Royal Bank of Canada Bullish on The Weir Group and Rightmove
Royal Bank of Canada (RBC) seems particularly optimistic about two companies. They boosted their price objective for The Weir Group (LON:WEIR) from GBX 2,500 ($31.98) to GBX 2,700 ($34.54), maintaining an "outperform" rating, signaling strong price appreciation potential. RBC also raised their price target for Rightmove (LON:RMV) from GBX 630 ($8.06) to GBX 750 ($9.59), while maintaining a "sector perform" rating, as reported by Digital Look.
“We see significant potential in The Weir Group, given their strong market position and innovative solutions,” stated a representative from RBC in a recent interview.
Other Notable Ratings
Science Group (LON:SAG) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group, with a price target of GBX 758 ($9.70), indicating a potential upside of 75.94%. 
On the other hand, Chardan Capital cut its price objective for Passage Bio (NASDAQ:PASG) from $7.00 to $6.00, although the stock retains a "buy" rating. Canaccord Genuity Group also weighed in on Passage Bio, supporting a positive outlook.
Repay Holdings Co. (NASDAQ:RPAY) experienced a setback, hitting a new 52-week low after Canaccord Genuity Group lowered their price target from $13.00 to $12.00, despite maintaining a "buy" rating on the stock. This demonstrates the complexities of market analysis, where a "buy" rating doesn't always guarantee short-term gains.
These analyst ratings and price target adjustments provide valuable insights for investors, but it's crucial to conduct thorough research and consider various factors before making investment decisions.